Fig. 3: Pre-treatment of ZLDI-8 enhances the efficiency of Sorafenib inducing MHCC97-H cells’ apoptosis. | Cell Death & Disease

Fig. 3: Pre-treatment of ZLDI-8 enhances the efficiency of Sorafenib inducing MHCC97-H cells’ apoptosis.

From: Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

Fig. 3

MHCC97-H cells, which were pretreated with 1 μmol/L ZLDI-8 or solvent control (1‰ DMSO), were treated with the IC50 concentration of Sorafenib. Cells were then harvested and analyzed for flow cytometer. The apoptosis of MHCC97-H cells were shown as the represented photographs or the apoptotic cell percentages. *p < 0.05 vs. Sorafenib or DMSO; *p < 0.05 vs. ZLDI-8 or DMSO

Back to article page